Cardiovascular Multimodality Imaging Study for Cardiomyopathies

This observational study aims to understand different types of heart muscle diseases (cardiomyopathies), including non-ischemic cardiomyopathy and cardiac amyloidosis, especially among Hispanic and African American communities in the Bronx. Researchers will use cardiovascular magnetic resonance (CMR) imaging, a special type of MRI for the heart, to gather information. The study is looking for 5000 adults, aged 18 and older, who are already scheduled for a CMR imaging study within the Montefiore Health System. The main goals are to track how long people live (mortality) and the occurrence of sudden cardiac death for up to five years after their initial CMR imaging. This study does not involve any new treatments or interventions; it focuses on observing and collecting data from existing medical imaging.

Study design
This is an observational study planning to include 5000 participants. It is not testing a new treatment but rather observing health outcomes.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 5 years after their initial CMR imaging to track mortality and sudden cardiac death.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06610019

Cardiovascular Multimodality Imaging Study

Recruiting
Not specifiedAges 18+Observational
Montefiore Medical Center
~10,000 participants
Updated 2026-08-10 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mortality
Measured over From index CMR imaging to time of chart review, up to 5 years
+1 more outcome measured
Non-ischemic Cardiomyopathy
Cardiomyopathies
Hypertrophic Cardiomyopathy
Right Ventricular Arrhythmogenic Cardiomyopathy
Cardiac Amyloidosis
Anderson Fabry Disease
Sarcoidosis
Cancer Therapy-related Cardiac Dysfunction
Ventricular Arrythmia
Heart Failure
1 sites across 1 states
New York1
  • Leandro Slipczuk, MD, PhD · PRINCIPAL_INVESTIGATOR · Montefiore Medical Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any adult patient (18 years or older) referred for a cardiovascular magnetic resonance (CMR) imaging study in the Montefiore Health System

Exclusion

Any patient who does not meet above criteria
  • MortalityFrom index CMR imaging to time of chart review, up to 5 years

    The number of patients who died from any cause will be summarized and reported using basic descriptive statistics.

  • Sudden Cardiac DeathFrom index CMR imaging to time of chart review, up to 5 years

    The number of patients who died from any cardiovascular-specific mortality will be summarized and reported using basic descriptive statistics.